6:34 PM
 | 
Feb 25, 2019
 |  BC Innovations  |  Distillery Techniques

Drug platforms

TECHNOLOGY: Cell therapy

A method for making iPS cells hypoimmunogenic could be used to generate allogeneic cell grafts for transplant therapies. The method involves two to three steps: simultaneous or sequential CRISPR-Cas9 (CRISPR-associated protein 9)-mediated deletion in an iPS cell line of β-2 microglobulin (B2M),...

Read the full 204 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >